Pipeline Reports

In a blind race to cure HIV, can Gene therapy be a deal-breaker?

Jun 26, 2020

HIV infection has become a global health burden, has claimed over 32 million lives so far since the very first case of AIDS was reported in 1981. According to a report put ...

Malignant Pleural Mesothelioma Upcoming Therapies

Jul 2, 2020

Malignant pleural mesothelioma treatment market includes several immunotherapy agents, in the pipeline including Keytruda, Opdivo and Yervoy, which have shown promising ant...

Malignant pleural mesothelioma market: Elusive treatment approaches and Poor diagnosis

Feb 14, 2020

Malignant pleural mesothelioma (MPM) is a malignancy of pleural layers within the lung cavity and inner sides of the ribs. Year of research has revealed asbestos expo...

Anaphylaxis: A Rare Disease

Jan 10, 2020

Anaphylaxis is a rare disease which can even result in life-threatening situations. Mostly the allergic reaction is due to food, insect stings, medications and latex. ...

Egg Allergy Market: Second most common food allergy but no approved therapy

Jun 30, 2020

Hen’s egg allergy is the second most common type of allergy after cow’s milk. In infants and young children, Egg poses as one of the most vital allergens degrading the ...

Chronic Hand Eczema Market Analysis and Forecast

Jun 26, 2020

Eczema is an umbrella term comprising skin disorders characterised by dry, discoloured, itchy and inflamed skin. Hand eczema (HE) are non-infectious, inflammatory cutaneous...

Angelman syndrome: A Rare Genetic Disorder

Apr 16, 2020

Angelman syndrome is a rare genetic disorder, which affects the nervous system. The people who are affected by the disease, show the characteristics like intellectual disab...

Reversing Ischemia with Gene therapy

Apr 9, 2020

A human body comprises of many small, long, narrow and broad blood vessels that carry oxygenated blood from the heart to other body parts for their normal functioning. Howe...

GBT, Syros; Takeda, Cevance collaborates; IND application to ZN-c3

Jul 2, 2020

Global Therapeutics and Syros Pharmaceuticals have teamed up to move forward to discover, develop and market novel Sickle cell disease and beta-thalassemia therapies. ...

Schizophrenia vs Bipolar disorder: Biomarkers to the rescue

Jun 30, 2020

Schizophrenia and Bipolar disorder (BD) are most of the times difficult to distinguish. Schizophrenia is characterized by hallucinations, and delusions when a patient loses...

Increasing cases of Mania and Bipolar disorder market

Apr 9, 2020

Bipolar Disorder is characterized by frequent-shifts in the mood and is a manic-depressive disorder hampering the routine life of an individual. According to the American P...

Novartis buys Medicines Co. for USD 9.7 Billion

Feb 14, 2020

Novartis plans to buy The Medicines Company for USD 9.7 Billion to gain access to a heart drug inclisiran, almost ready to get into the market. Under the terms of the deal,...

GHO to advance healthcare in Europe; Truvian nets USD 27.1 Mn; Lilly plans its diabetes portfolio expansion

Feb 14, 2020

Global Healthcare Opportunities (GHO) Capital, a London-based healthcare investment firm, has recently netted USD 1.1 Billion to advance European healthcare. The company pl...

AbbVie Sells bonds to Fund Allergan takeover

Jun 29, 2020

AbbVie has traded off its bonds worth USD 30 Billion to finance the purchase of the Allergan. AbbVie this year in June has agreed to buy Allergan for USD 63 Billion,...

Non-small cell lung cancer emerging therapies

Feb 5, 2020

The Non-small cell lung cancer therapeutics market is anticipated to improve owing to better diagnostics methodologies and treatment options across the world. This would ex...